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Introduction
Malaria in pregnancy, especially among HIV positive pregnant 
mothers, is a major cause of  morbidity and mortality in sub-
Saharan Africa. Malaria infection during pregnancy is indeed 
a major public health challenge in tropical and subtropical 
regions throughout the world1. Studies have established 
that malaria and HIV are among the two most important 
diseases contributing to the global health burden of  our 
time and,  together, they cause more than 4 million deaths 
every year2,3.  Nearly 40% of  the world’s population lives 
in infected regions4. Every year, approximately 50 million 
women become pregnant in malaria endemic regions.5 
Approximately 1 million are estimated to be infected with 
both malaria and HIV which are preventable, and responsible 
for serious maternal and neonatal morbidity5. Malaria 
transmission is intense and occurs all year round in Nigeria6. 
It has been shown that at least 3 million pregnancies occur 
among women in malarious areas of  Africa, most of  whom 
reside in areas of  relatively stable malaria transmission6. A 
good number of  HIV infected individuals live in regions 
with different levels of  malaria transmission7. Several studies 
have reported that malaria is a major public health problem 
affecting 300-500 million people annually8,9. .It is also a major 
cause of  maternal and infant morbidity and mortality in sub-
Saharan Africa10,11.
Much work has been done to show the relationship between 
malaria and HIV in pregnancy. Some studies among pregnant 
women in Sub-Saharan Africa have provided evidence 
of  an important public health problem arising from the 
interaction of  HIV and malaria. A study in Ibadan, south 
western Nigeria, revealed that HIV positive pregnant women 
had higher malaria parasite levels than those not infected 
with HIV12. This result was confirmed by another study in 
Abakaliki, south-eastern Nigeria13. In addition, data from 
Malawi suggested that infants exposed to both placental 
malaria and maternal HIV infection have a 3-8 fold increased 
risk for post neonatal death higher than infants born to 
mothers with either infection alone14.
Some economists have estimated that the Gross Domestic 
Product (GDP) of  African governments is reduced by $12 
billion annually as a result of  malaria infection2. It has also 
been estimated that up to 132 billion naira is spent  each year 
on  malaria treatment in Nigeria11. Although over-a-century 
of  work to control or eradicate malaria has been done, more 
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Globally, malaria in pregnancy is a public health challenge. Malaria and HIV are among the two most important diseases contributing 
to the global health burden of  our time. HIV positive pregnant women are at increased risk of  all the adverse outcomes of  malaria in 
pregnancy.
Objective    
The objective of  this study was to compare malaria parasitaemia between HIV positive and HIV negative pregnant women attending 
antenatal clinics offering Preventing Maternal to Child Transmission (PMTCT) services in Enugu metropolis, south-eastern Nigeria.
Methods
A descriptive cross sectional study was conducted among 200 HIV positive and 200 HIV negative pregnant women attending antenatal 
clinics in Enugu.  Two out of  five hospitals that provide PMTCT services were selected through balloting. Finger pricked blood samples 
were collected and thick blood films were examined for malaria parasite using giemsa expert microscopy. A structured interviewer 
administered questionnaire was used for data collection. Data was analysed using SPSS version 22.
Results
The HIV positive pregnant women (152) (76%) and HIV negative women (137) (68.5%) studied were mostly in the age range of  
25-34 years. Mean gestational age of  HIV positive and HIV negative participants were 23.4±10.7 and 23.2±10.1 weeks respectively 
(P=0.001).  The prevalence of  malaria infection among HIV positive pregnant mothers was 81% (162/200) and 75% (150/200) among 
HIV negative pregnant women (P < 0.001). The HIV positive mothers had more moderate parasitaemia (86/200: 53.1%) compared 
to 43/200: 28.7% in HIV negative mothers (P<0.001). Even though more HIV positive mothers (54.5%) used insecticide treated 
nets ITNs during pregnancy compared to 41.5% in HIV negative mothers, moderate malaria parasitaemia was higher in HIV positive 
mothers.  HIV positive nulliparous pregnant women had the highest rate of  malaria parasitaemia (32/36: 88.9%).
Conclusion 
Moderate malaria parasitaemia was higher among HIV positive pregnant women. All malaria preventive strategies should be intensified 
in pregnancy as ITNs provided little protection.
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health implications of  malaria and HIV in pregnancy15. In 
malaria endemic areas, including Enugu State, malaria may 
account for up to 15% of  maternal anaemia and 5-14% of  
Low Birth weight (LBW)16. Anaemia due to malaria causes 
up to 10,000 maternal deaths each year16. Available data 
indicates that Enugu State has very high maternal mortality 
with figures ranging from 772 to 998 per 100,00017,18. This 
is almost thrice the figure (286/100,000) reported for the 
entire southeast zone, and almost double the 545/100,000 
national averages for the seven years period preceding the 
2008 National Demographic and Health Survey19.
At present, maternal mortality ratio in Enugu State 
approximates close to the national ratio of  1,000 maternal 
deaths per 100,000 live births19. Malaria and anaemia in 
pregnancy, amongst other causes, have been seriously 
associated with this high rate of  maternal deaths19.  Several 
studies have documented evidence that HIV impairs malaria 
immunity among pregnant women, because pregnant women 
infected with HIV demonstrate more frequent and higher 
density parasitaemia than pregnant women not infected with 
HIV20-23. The aim of  this research was to compare malaria 
parasitaemia between HIV positive and HIV negative 
pregnant women attending antenatal clinics offering PMTCT 
services in Enugu metropolis, south-eastern Nigeria.
Materials And Methods
Study area 
Enugu State is one of  the six states in the south eastern 
part of  Nigeria. It shares boundaries with Anambra, Abia, 
Kogi, Benue and Ebonyi States. The 2006 census recorded 
its population as 1,596,042 males and 1,671,795 females24. 
Enugu State has rich agricultural land because of  its location 
within the tropical forest and savannah belts.
Study design and sampling technique
A simple random sampling technique, balloting, was used 
to select two from the five hospitals with maternal health 
services that offered PMTCT services in Enugu metropolis. 
The sample constituted 400 pregnant women that were 
consecutively selected during their registration exercise 
(booking) from the antenatal register. There were 200 
HIV positive and 200 HIV negative pregnant women who 
were selected and those who consented were recruited for 
the study. Sample size was calculated using a formula for 
calculating sample size from a finite population using a 
previous prevalence of  malaria infection in HIV positive 
pregnant women12. Any woman that did not give consent 
was replaced with the next consenting woman.
Specimen collection and data collection
Finger pricked blood samples were collected and thick 
blood films were made. The films were examined for 
malaria parasite using Giemsa expert microscopy. The socio-
demographic data of  respondents were collected using a 
structured interviewer administered questionnaire. HIV 
status was determined from the blood test results retrieved 
from the respondent’s folders.
Data analysis
Data collected was analysed using SPSS version 17 (SPSS Inc, 
Chicago, Illinois, USA). Relationship of  various variables and 
Chi-square was used to determine significance at p<0.05. 
Mild parasitaemia refers to levels of  1-999 mp/ml, moderate 
refers to 1000-9999 mp/ml, and high refers to >10,000 mp 
/ml. The parameters considered in the analysis included age, 
gestational age, parity and gravidity. 
Ethical approval
Ethical approval was obtained from the Health Research 
Ethics Committees of  the University of  Nigeria Teaching 
Hospital and Annunciation Specialist Hospital, Enugu. 
Informed written consent was obtained from the participants. 
Results
Socio-demographic characteristics of the study 
population
Table 1 shows the age range of  HIV positive pregnant 
women and negative women who were enrolled for the 
study. Above half  (106) (53%) had secondary education and 
64 (32%) had tertiary education amongst the HIV positive 
women, whereas 92 (46%) and 74 (37.0%) had tertiary and 
secondary education, respectively, among the HIV negative 
women. Majority of  the respondents were married, 188 
(94%) and 190 (95%) for HIV positive and HIV negative 
mothers respectively. Occupations included trading (103)
(51.5%) and civil service (34) (17%). Among the HIV 
positive respondents, 18% (36/200) were primigravidae, 
38% (76/200) were secundigravidae and 44% (88/200) 
were multigravidae.  Some of  the mothers (23%) (46/200) 
were in their first trimester, 37% (74/200) in  the second 
trimesters, while the remaining 40.5% (80/200) were in their 
last trimester. The parity revealed that 18% (36/200) of  the 
HIV positive women  were nullipara (had no children at 
the time of  pregnancy), 31% (62/200) had one child  and 
majority of  them, 51% (102/200), had given birth to two or 
more children (multipara). In the HIV negative population, 
20.5%, 40% and 39.5% were in the first, second and third 
trimester respectively. Primigravidae constituted 12%, 
secundigravidae were 32%  and multigravidae constituted 
56% of  the mothers. Concerning parity, 33.5%, 23.0% and 
43.5% were nullipara, primipara and multipara respectively.
Gestational age and CD4 counts of the study 
population 
Table 2 shows that the mean gestational age was 23.4±10.7 
weeks for HIV positive women and 23.2±10.1 weeks for 
HIV negative pregnant women.   Among the HIV positive 
women 64 (32%) had CD4 levels of  ≤250 cells/mm3 and 
136 (68%) of  the pregnant women had CD4 levels ≥250 
cells/mm3.
Malaria parasitaemia in the study population  
Figure 1 shows that the prevalence of  malaria infection 
for HIV positive pregnant women was 81% (162/200) 
and 75% (150/200) for HIV negative pregnant women. 
Table 3 shows that out of  the 162 HIV positive pregnant 
women with parasitaemia, 76/162 (46.9%) had mild (1-999/
uL) infection, 86/162 (53.1%) had moderate (1000-9999/
uL) malaria infection and none of  the women had high 
malaria parasitaemia.  Among the HIV negative women, 
107/150 (71.3%) had mild parasitaemia, 43/150(28.7%) had 
moderate and 50/150 (25%) no parasites seen and none had 
severe parasitaemia. There was a highly significant difference 
in degree of  parasitaemia between HIV positive and HIV 
negative women.
Relationship between malaria prevalence and 
gravidity, trimester and parity 
Table 4 shows that among HIV positive pregnant women, 
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primigravidae and secundigravidae following closely with 
38/49: 77.6% and 46/59:78% respectively. HIV negative 
women in their first trimester had the highest malaria 
parasitaemia with 35/41:85% Tables 4 and 5 show that the 
distribution of  malaria among HIV positive pregnant women 
was higher at all levels compared to HIV negative pregnant 
women. Malaria prevalence was higher among HIV positive 
pregnant women that were Secundigravidae (84.0%) and 
Multigravidae (86.4%) compared to HIV negative women 
(78.0%) and 71.1% at the same gravid levels respectively. The 
prevalence among the primigravidae that were HIV negative 
was 77.6% compared with the HIV positive group at the same 
gravida level (61.1%). More of  the HIV negative women had 
mild infection compared to HIV positive pregnant women. 
The difference in the distribution of  malaria among the two 
groups was statistically significant (P<0.05). The highest 
malaria prevalence among HIV infected pregnant women 
occurred between the ages of  30 – 34years (88.4%), while 
the least occurred between the age of  15 to 19 years. The 
differences in the result of  this distribution was statistically 
significant (P<0.05). Few women with no formal education 
(4) participated among the HIV positive mothers and scored 
the highest malaria prevalence (100%) and the least malaria 
prevalence was found among those with secondary and 
primary education. Pregnant women with tertiary education 
recorded high malaria prevalence for both HIV positive and 
HIV negative group (93.8% and 82.6% respectively), with 
HIV positive pregnant women having more. The trimester 
related prevalence result of  HIV positive pregnant women 
compared to HIV negative women shows that HIV positive 
women had the highest level of  malaria prevalence at all 
trimester levels (78.3%, 77.0% and 86.3%) compared to HIV 
negative women (85.4%, 71.3%, 73.4%). The difference in the 
distribution of  malaria among the two groups was statistically 
significant (P<0.05). The parity related prevalence result of  
the multigravidae were found to have the highest malaria 
prevalence with 76/88 (86.4%); while the primigravidae 
had the least malaria prevalence, 22/36 (61.1%). Women 
in their third trimester were mostly affected (79/80:98.8%) 
while those in their first trimester had the least prevalence 
(26/46:56.5%). The distribution of  malaria among different 
parity groups showed that nullipara (32/36: 88.9%) were 
more affected than the multipara (46/102: 45.1%).
In their HIV negative counterparts (Table 5), multigravidae 
had the least malaria parasitaemia (66/92: 71.7%) with the 
Variables Categories        HIV Positive 
   N                        %
       HIV Negative
N                            %
Age Group 
(Years)
15-19 0 0 2 1.0
20-24 14 7.0 26 13.0
25-29 66 33.0 74 37.0
30-34 86 43.0 63 31.5
35-39 26 13.0 25 12.5
40-44 8 4.0 10 5.0
Education
 Level
None 4 2.0 3 1.5
Primary 26 13.0 31 15.5
Secondary 106 53.0 74 37.0
Tertiary 64 32.0 92 46.0
Marital 
Status
Single 2 1.0 2 1.0
Married 188 94.0 190 95.0
Widowed 10 5.0 8 4.0
Occupation Civil servants 34 17.0 41 20.5
Teachers 18 9.0 5 2.5
Traders 103 51.5 71 35.5
Health workers 13 6.5 16 8.0
House wives 21 10.5 3 1.5
Others 11 5.5 61 30.5
Trimester 1st 46 23.0 41 20.5
2nd 74 37.0 80 40.0
3rd 80 40.5 79 39.5
Gravidity Primigravidae 36 18.0 24 12.0
Secundigravidae 76 38.0 64 32.0
Multigravidae 88 44.0 102 56.0
Parity Nullipara 36 18.0 67 33.5
Primipara 62 31.0 46 23.0
Multipara 102 51.0 87 43.5
Table 1: Socio-demographic characteristics of HIV positive and 
HIV negative work participants
Table 2: Relationship of some variables with HIV positive and 
negative participants
Variables HIV Positive =200 HIV Negative N=200 P-value
Age(years) Mean ± Sd 37±6.1 35.6±5.4 0.001
Gestational age in months 5.4±2.48 5.38±2.34 0.001
PCV (%) mean± SD 35.34±3.78 28±3.2 0.005
CD4 Levels
≤250 cells/mm3 64 (32.0%) N/A
>250 cells/mm3 136(68.0%) N/A
Total 200 200
Table 3:  Malaria Parasitaemia  among HIV Positive and HIV 
Negative participants
Malaria Parasite (MP)             HIV Positive
  n                                 %
           HIV Negative
n                             %
P-Value
Not seen 38 19.0 50 25.0
P<0.001
Mild (1-999) 76 46.9 107 71.3
Moderate 
(1000-9999)
86 53.1 43 28.7
High 0 0 0 0
Figure 1: Prevalence of Malaria infection in HIV positive and HIV 
negative pregnant women
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HIV positive pregnant women compared to HIV negative 
women shows that HIV positive women had the highest level 
of  malaria prevalence at all parity levels (nullipara (88.9%), 
primipara (80.4%_ and multipara(81.0%) compared to HIV 
negative mothers (nullipara (71.6%), primipara (76.1%) and 
multipara (77.0%). Among HIV positive pregnant women, 
the nullipara groups had the highest malaria prevalence 
(88.9%) whereas among the HIV negative groups, the 
Category Variables No Examined
N               
No Malaria
Seen
N      %
Mild Infection
N     % 
Moderate
Infection
N      %
Total Malaria 
Prevalence
N     %
P-Value
Trimester 1st 46 20(43.5) 16(61.5 10(38.5) 26(56.5%)
2nd 74 17(22.9) 25(43.9) 32(56.1) 57(77.0%) <0.0001
3rd 80 1(1.3) 45(57.0) 34(43.0) 79(98.8%)
Parity Nullipara 36 4             11.2 16     44.4 16       44.4 32             88.8
< 0.0001Primipara 62 12          19.4 29     46.8 21        33.8 50             80.6
Multipara 102 56          54.9 20     19.6 26        25.5 46             45.1
Gravidity Primigravidae 36 14         38.9 14     38.9 8          22.2 22             61.1
< 0.05Secundigravidae 76 12         15.8 36     47.4 28        36.8 64             84.0
Multigravidae 88 12         13.6  36     40.9 40        45.5 76             86.4
CD4 Count ≤250 Cells/mm3 64 16          25.0 24     37.5 24        37.5 48             75.0
< 0.0001>250 cells/mm
3 136 22          16.2 60    44.1 54        39.7 114          83.8
Age grp(years) 15 – 19 0 0               0 0           0 0              0 0                  0
<0.005
20 – 24 14 4            28.6 4        28.6 6          42.8 10             71.4
25 – 29 66 16          24.2 32     48.5 18        27.3 50             75.8
30 – 34 86 10          11.6 34     39.5 42        48.9 76             88.4
35 – 39 26 4            15.4 12     46.2 10        38.4 22             84.6
40 – 44 8 4            50.0 4        50.0 0             0 5               62.5
E d u c a t i o n a l 
Level
None 4 0              0 2        50.0 2          50.0 4               100
<0.0001Primary 26 6            23.0 10     38.5 10        38.5 20             76.9
Secondary 106 28          26.4 50     47.2 28        26.4 78             73.6
Tertiary 64 4              6.3 24     37.5 36        56.2 60             93.8
Table 4: Relationship between factors and prevalence of malaria among HIV positive participants
Category Variables No Examined
N                
No Malaria
Seen
N               %
Mild Infection
N           % 
Moderate
Infection
N              %
Total Malaria 
Prevalence
N                  %
P-Value
Parity Nulipara 67 19          41.3 33       71.7 15          32.6 48           71.6 <0.0001
Primipara 46 11          16.4 26       38.8 9           13.4 35           76.1
Multipara 87 20          23.0 50       57.5 17         19.5 67           77.0
Gravidity Primigravidae 49 11          22.4 27      71.1 11         28.9 38           77.6
Secungravidae 59 13          22.0 29      63.0 17         37.0 46           78.0
Multigravidae 92 26          28.3 51       77.3 15         22.7 66           71.7
Age grp(Yrs) 15 – 19 2 0            0.0 0           0.0 2          100.0 2            100.0
20 – 24 26 5            19.2 13       61.9 8         38.1 21           80.8
25 – 29 74 25          33.8 40      81.6 9         18.4 49           66.2
30 – 34 63 12          19.0 35      68.6 16       31.4 51           81.0
35 – 39 25 3            12.0 14      63.6 8         36.4 22           88.0
40 – 44 10 5             50.0 5         100. 0           0.0 5             50.0
E d u c a t i o n a l 
Level
None 0 0 0 0 0
Primary 34 14          45.2 14      41.2 6          35.3 17            54.8
Secondary 74 20.         27.0 38      70.4 16        29.6 54            73.0
Tertiary 92 16          17.4 55      72.4 21        27.6 6               82.6
Table 5: Relationship of factors and Prevalence of Malaria among HIV Negative participants
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multipara had the highest malaria prevalence rate of  (77%). 
The difference in the distribution of  malaria among the 
two groups was statistically significant (P<0.05). Table 6 
shows that both HIV positive and negative mothers that use 
ITNs had lower levels of  parasetaemia (75.5% and 73.6%) 
compared to those that did not use ITNs (89.4% and 89.4%). 
This was found to be statistically significant (P<0.05).
Table 6: Use of ITNs and parasitaemia among HIV positive and 
negative participants
Discussion
Malaria parasitaemia was mostly mild to moderate in 
both HIV positive and HIV negative pregnant mothers. 
This prevalence agrees with results of  a study Olusi and 
Abe where prevalence of  malaria in pregnant women was 
found to be  96.92%, with majority (93.17%) infected 
with low parasitaemia25. Similarly, Cameroon  recorded 
high  malaria prevalence  of  86.5%.26 This prevalence 
differs  from findings in a previous study in Enugu that 
documented only 49.83% of  HIV positive pregnant women 
with malaria27. Our study revealed a statistically significant 
difference concerning distribution of  malaria parasitaemia 
density among HIV positive pregnant mothers  and their 
HIV negative counterparts (P<0.05). Some studies have 
reported that HIV and AIDS causes immunosuppression 
thereby reducing the overall immune response to malaria 
parasitaemia, thus increasing the frequency of  clinical attacks 
of  malaria28. This agrees with previous studies carried out in 
southeastern and southwestern Nigeria where susceptibility 
to malaria among HIV positive mothers was higher than HIV 
negative mothers29. In this study, the HIV negative pregnant 
mothers had more mild malaria infection than HIV positive 
mothers. However, moderate malaria infection was more 
in HIV positive mothers. The result of  these differences in 
malaria density was statistically significant (P<0.05). No high 
malaria prevalence was recorded among both HIV positive 
and HIV negative mothers (i.e. Parasite Density = 10,000/
uL). However, a recent study in rural areas of  southeast 
Nigeria reported cases of  high malaria prevalence in contrast 
to this study26. A possible factor could be that the national 
guideline recommends cotrimoxazole for HIV positive 
pregnant mothers and intermittent preventive therapy 
(IPTp) for HIV negative pregnant mothers which has been 
documented to avert severe malaria attacks among pregnant 
mothers30. Some studies have generally reported HIV as a 
major risk factor for malaria transmission in pregnancy, and 
have also reported HIV in pregnancy as a double burden 
for high malaria parasitaemic density in pregnancy due to 
immmunosuppression28.  There was a statistically significant 
difference (P<0.05) between the HIV positive and negative 
mothers that used ITNs for the prevention of  malaria. More 
HIV positive mothers used ITNs compared with the HIV 
negative mothers even though the HIV positive mothers had 
a higher prevalence of  malaria infection. Those women that 
used ITNs were less infected than those who did not. This 
difference could probably be due to the pre-existing health 
condition that influenced better health practices. 
The age related distribution of  malaria parasitaemia showed 
that malaria prevalence was higher in women of  age group 
40-44 years and least prevalent among the 25-29 age range 
group in the HIV positive pregnant mothers.  Our study found 
that the age group of  15-19 years among the HIV negative 
mothers had 100% malaria prevalence. Education should 
have a positive influence on malaria prevention substantiated 
by the fact that a previous study revealed that participants 
who satisfactorily responded to the questions about malaria 
transmission and prevention were less affected by malaria as 
compared to those who had a poor knowledge31.Surprisingly, 
pregnant mothers with tertiary education recorded high 
malaria prevalence for both HIV positive and negative 
mothers in this study. In addition, this study observed that 
the illiterate pregnant women had the highest rate of  malaria 
probably because they were more exposed to malaria parasite 
due to bad environmental condition and their lifestyles31. 
The parity related prevalence showed that HIV positive 
mothers who had not given birth before (nullipara) had 
the highest malaria prevalence while the pregnant mothers 
with two children and above (multipara) had the least 
malaria prevalence. At all parity levels, malaria prevalence 
was higher among HIV positive mothers compared to HIV 
negative mothers where the multipara group had the highest 
prevalence.  This is consistent with findings from another 
study by Rogerson et al, where significant differences were 
seen among parity groups32. In our study, the multigravidae 
had the highest malaria prevalence while primigravidae had 
the least malaria prevalence among HIV positive mothers. 
On the other hand, among the HIV negative pregnant 
mothers, primigravidae had the highest malaria prevalence, 
(77.6%). This is consistent with a study that showed that 
among the HIV negative mothers, the primigravidae are 
more susceptible to high malaria prevalence33. The drug 
related malaria distribution showed that majority of  the 
HIV positive pregnant mothers, 128(64%), did not take 
antimalaria therapy which can also be strongly linked to the 
reason for high malaria prevalence in this study. One of  
the most important factors for these observed differences 
in malaria parasitaemia among HIV positive and negative 
patients could be explained by the fact that HIV pregnant 
mothers have a compromised immunity due to low CD4 
level. The immunosuppression caused by HIV virus leads 
to high malaria prevalence as has been documented34. From 
this study, it was obvious that women who used ITNs were 
less infected than women who did not. Studies have strongly 
supported and concluded on the fact that ITNs coverage was 
related to malaria control, has significantly reduced malaria 
and was associated with a malaria risk-protective effect28. 
Limitations of the study
The limitation of  this study includes the fact that populations 
not visiting a hospital were not included in the study.
Conclusion
In this study, moderate malaria parasitaemia was commoner 
among HIV positive pregnant mothers than among HIV 
negative andITNs provided little protection against malaria 
in pregnancy among HIV positive pregnant mothers. It is 
therefore recommended that all malaria preventive strategies 
should be intensified in pregnancy especially among HIV 
positive women.
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